ABT : Summary for Abbott Laboratories Common Stoc - Yahoo Finance

U.S. Markets open in 2 hrs 46 mins

Abbott Laboratories (ABT)

NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
38.42-0.01 (-0.03%)
At close: 4:03 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close38.43
Bid36.61 x 200
Ask39.43 x 200
Day's Range38.22 - 38.65
52 Week Range36.00 - 46.22
Avg. Volume8,383,554
Market Cap56.57B
PE Ratio (TTM)41.94
Earnings DateN/A
Dividend & Yield1.04 (2.74%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire23 hours ago

    Study: Hospital Nutrition Program Shortens Patient Stays and Reduces Readmissions

    DOWNERS GROVE, Ill. and ABBOTT PARK, Ill., Dec. 6, 2016 /PRNewswire/ -- While proper nutrition is vital to staying healthy, its importance becomes more critical for patients recovering in the hospital.  A new study by Advocate Health Care and Abbott (ABT) found that optimizing nutrition care in the hospital could help reduce 30-day readmission rates by 27 percent and the average hospital stay by almost two days for malnourished patients. Across the U.S., 1 in 3 people enter the hospital malnourished, which can often go unrecognized and undertreated.2-3 To help improve care for malnourished patients, Advocate implemented two versions of a nutrition care program – basic and enhanced – at four of its Chicagoland hospitals. Both programs required care teams to conduct patient malnutrition risk screenings using a validated tool on the hospitals' electronic medical records system, and provide nutrition treatment and support for malnourished or at-risk patients.

  • 24/7 Wall St.2 days ago

    4 Merrill Lynch Med Tech and Drug Dividend Stocks to Buy With Huge 2017 Potential

    These are stocks that make good sense for investors looking to add to their overall equity holdings. They are all trading well below their 52-week highs and should be attracting substantial institutional ...

  • Zacks5 days ago

    MedTech Sails Through Macro Woes: Stocks in Focus

    MedTech Sails Through Macro Woes: Stocks in Focus